Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Multifunctional Iron Platinum Stealth Immunomicelles: Targeted Detection Of Human Prostate Cancer Cells Using Both Fluorescence And Magnetic Resonance Imaging
R. Taylor, D. Huber, T. Monson, Abdul-Mehdi S. Ali, M. Bisoffi, L. Sillerud
Published 2011 · Materials Science, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Superparamagnetic iron oxide nanoparticles (SPIONs) are the most common type of contrast agents used in contrast agent-enhanced magnetic resonance imaging (MRI). Still, there is a great deal of room for improvement, and nanoparticles with increased MRI relaxivities are needed to increase the contrast enhancement in MRI applied to various medical conditions including cancer. We report the synthesis of superparamagnetic iron platinum nanoparticles (SIPPs) and subsequent encapsulation using PEGylated phospholipids to create stealth immunomicelles (DSPE-SIPPs) that can be specifically targeted to human prostate cancer cell lines and detected using both MRI and fluorescence imaging. SIPP cores and DSPE-SIPPs were 8.5 ± 1.6 nm and 42.9 ± 8.2 nm in diameter, respectively, and the SIPPs had a magnetic moment of 120 A m2/kg iron. J591, a monoclonal antibody against prostate specific membrane antigen (PSMA), was conjugated to the DSPE-SIPPs (J591-DSPE-SIPPs), and specific targeting of J591-DSPE-SIPPs to PSMA-expressing human prostate cancer cell lines was demonstrated using fluorescence confocal microscopy. The transverse relaxivity of the DSPE-SIPPs, measured at 4.7 Tesla, was 300.6 ± 8.5 s−1 mM−1, which is 13-fold better than commercially available SPIONs (23.8 ± 6.9 s−1 mM−1) and ~3-fold better than reported relaxivities for Feridex® and Resovist®. Our data suggest that J591-DSPE-SIPPs specifically target human prostate cancer cells in vitro, are superior contrast agents in T2-weighted MRI, and can be detected using fluorescence imaging. To our knowledge, this is the first report on the synthesis of multifunctional SIPP micelles and using SIPPs for the specific detection of prostate cancer.
This paper references
Prostate-Specific Membrane Antigen: Much More Than a Prostate Cancer Marker.
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
R. E. Sobel (2005)
Recent development and application of magnetic nanoparticles for cell labeling and imaging.
Chao Zhang (2010)
Synthesis of monodispersed gamma-Fe2O3 nanoparticles using ferrocene as a novel precursor.
G. Bhalerao (2009)
Determination of Nanocrystal Size Distribution in Magnetic Multicore Particles Including Dipole‐Dipole Interactions and Magnetic Anisotropy: a Monte Carlo Study
Vincent Schaller (2010)
Recent Advances in Chemical Synthesis, Self‐Assembly, and Applications of FePt Nanoparticles
S. Sun (2006)
Enhanced orbital magnetism in Fe(50)Pt(50) nanoparticles.
C. Antoniak (2006)
Structure and magnetic properties of iron–platinum particles with γ-ferric-oxide shell
L. Basit (2008)
Cancer Statistics, 2010
A. Jemal (2010)
Stoichiometry–anisotropy connections in epitaxial L10 FePt(001) films
K. Barmak (2004)
Update on prostate imaging.
Jalil Afnan (2010)
High gradient magnetic cell separation with MACS.
S. Miltenyi (1990)
PEGylation for improving the effectiveness of therapeutic biomolecules.
G. Pasut (2009)
Size-dependent properties of magnetic iron oxide nanocrystals.
A. Demortière (2011)
HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.
Hee-Man Yang (2010)
Relaxation times of colloidal iron platinum in polymer matrixes
M. Morales (2009)
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
Superparamagnetic FePt nanoparticles as excellent MRI contrast agents
S. Maenosono (2008)
Effect of large boron additions to magnetically hard Fe‐Pt alloys
K. Inomata (1988)
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Xiang-hong Peng (2008)
Formation of monodisperse FePt alloy nanocrystals using air-stable precursors: fatty acids as alloying mediator and reductant for Fe3+ precursors.
F. Zhao (2009)
Dispersible Ferromagnetic FePt Nanoparticles
J. Kim (2009)
Targeting and Cellular Trafficking of Magnetic Nanoparticles for Prostate Cancer Imaging
R. Serda (2007)
Saporin toxin‐conjugated monoclonal antibody targeting prostate‐specific membrane antigen has potent anticancer activity
K. Kuroda (2010)
Water-based ferrofluids from FexPt1-x nanoparticles synthesized in organic media.
V. Salgueiriño-Maceira (2004)
Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids.
M. Johnsson (2003)
Magnetic properties of iron oxide nanoclusters within microdomains of block copolymers
Byeong-Hyeok Sohn (1998)
Prostate‐specific membrane antigen
W. Fair (1997)
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.
K. A. Hinds (2003)
Is prostate-specific membrane antigen a multifunctional protein?
A. K. Rajasekaran (2005)
The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
D. Patel (2011)
Incidence and clinical significance of false-negative sextant prostate biopsies.
F. Rabbani (1998)
Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices
Electronic and Magnetic Properties of Ligand-Free FePt Nanoparticles†
Hans-Gerd Boyen (2005)
Engineered Biocompatible Nanoparticles for in Vivo Imaging Applications
S. Chen (2010)
Self-assembled FePt nanocrystals with large coercivity: reduction of the fcc-to-L1(0) ordering temperature.
L. C. Varanda (2006)
Fe oxidation versus Pt segregation in FePt nanoparticles and thin films.
L. Han (2009)
FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition.
C. Xu (2009)
Multi-stage delivery nano-particle systems for therapeutic applications.
R. Serda (2011)
Exchange-coupled nanocomposite magnets by nanoparticle self-assembly
H. Zeng (2002)
One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals.
A. Figuerola (2008)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A. Ghosh (2004)
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
A. M. Wolf (2010)
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
P. Wolf (2010)
This paper is referenced by
Immunomicelles for advancing personalized therapy.
R. Sawant (2012)
Low-toxicity FePt nanoparticles for the targeted and enhanced diagnosis of breast tumors using few centimeters deep whole-body photoacoustic imaging
Y. Liu (2020)
Multifunctional iron platinum stealth immunomicelles: Targeted imaging and therapy of prostate cancer
R. Taylor (2012)
Conjugação de anticorpo anti-antígeno carcinoembrionário a nanopartículas magnéticas : avaliação do potencial para detecção e tratamento de câncer
Mariana Campos da Paz Lopes (2012)
Magnetic nanoformulations for prostate cancer.
P. Chowdhury (2017)
Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
Nathan O Solberg (2014)
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
J. Elgqvist (2017)
Recent Advances in the High‐Temperature Chemical Synthesis of Magnetic Nanoparticles
A. Mendoza-Garcia (2016)
Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
Fan Pu (2016)
Characterization of magnetic nanoparticle by dynamic light scattering
J. Lim (2013)
MRI contrast demonstration of antigen-specific targeting with an iron-based ferritin construct
E. Walsh (2013)
Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r₂ relaxivity for highly sensitive in vivo MRI of tumors.
N. Lee (2012)
In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles
Yunkai Zhu (2015)
Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis.
Khalid Oumzil (2016)
Methodology and phantom studies for the development and assessment of motion correction in simultaneous PET-MR
G. Soultanidis (2015)
Quantitative [Fe]MRI determination of the dynamics of PSMA‐targeted SPIONs discriminates among prostate tumor xenografts based on their PSMA expression
L. Sillerud (2018)
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease
J. C. Evans (2016)
Immuno Magnetic Thermosensitive Liposomes For Cancer Therapy
Mohamad Alawak (2019)
High pressure synthesis of FePt nanoparticles with controlled morphology and Fe content
L. A. W. Green (2014)
Influence of carbon chain length on the synthesis and yield of fatty amine-coated iron-platinum nanoparticles
R. Taylor (2014)
Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor
H. Chen (2016)
Multicore magnetic FePt nanoparticles: controlled formation and properties
L. A. W. Green (2014)
Prostate cancer targeting motifs: Expression of ανβ3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts
R. Taylor (2012)
SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
L. Sillerud (2013)
Nanoscience and Nanotechnology: Issues and Applications in Agri-Food, Biomedical, and Environmental Sciences
Saikh Mahammed (2012)
Oligonucleotide-based theranostic nanoparticles in cancer therapy.
R. Shahbazi (2016)
Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer
Mariana Campos da Paz (2012)
Structural and Magnetic Characterization of Superparamagnetic Iron Platinum Nanoparticle Contrast Agents for Magnetic Resonance Imaging.
R. Taylor (2012)
Longitudinal monitoring of microglial/macrophage activation in ischemic rat brain using Iba-1-specific nanoparticle-enhanced magnetic resonance imaging
L. Sillerud (2020)
Superior Magnetic Performance in FePt L10 Nanomaterials.
Kwanghyo Son (2019)
Superparamagnetic nanoparticle‐enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization
Marissa Tafoya (2017)
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner
R. Taylor (2012)See more